More than a year into a strategic pivot to zero in on the multiple myeloma cell therapy Abecma, 2seventy bio is selling itself to partner Bristol Myers Squibb. Bristol Myers has agreed to buy out ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) (“BMS”) will acquire all of the ...

Abecma made $406 million in 2024, of which BMS paid $43 million to 2seventy bio as part of their profit-sharing agreement. Bristol Myers Squibb is stepping in to buy its Abecma partner 2seventy bio ...

Summary: Researchers have discovered how specific brain circuits process empathy, showing that witnessing others in pain activates the same neural pathways as experiencing pain directly. Using ...

-i, --input Required. input folder, the program will recursively search for available BMS beatmaps from this folder, available BMS beatmaps: .bms/.bml/.bme/.bmx -o, --output Required. output folder ...